Medicines labeled for the same conditions
Alternatives to memantine
3 other medicines are given the same way (oral) and in the same FDA class as memantine or labeled mainly for the same use (alzheimer's disease); the others include 3 cholinesterase inhibitors (FDA labels read October 8, 2026).
Which medicines are labeled for the same conditions as memantine?
Alzheimer's disease lists all 7 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (oral) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Memantinen-methyl-d-aspartate receptor antagonist | this medicine | 38 labelers | $0.063 per tablet 10 mg tablet | No | No current entry |
| Donepezilcholinesterase inhibitor | Alzheimer's disease | 31 labelers | $0.0484 per tablet 10 mg tablet | No | No current entry |
| Rivastigminecholinesterase inhibitor | Alzheimer's disease | 11 labelers | $0.164 per capsule 1.5 mg capsule | No | A presentation being discontinued |
| Galantaminecholinesterase inhibitor | Alzheimer's disease | 9 labelers | $0.294 per tablet 4 mg tablet | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Memantine: the full record
- label, generics, price, shortages, recalls
- Memantine vs donepezil
- two records side by side
- Rivastigmine vs memantine
- two records side by side
- Galantamine vs memantine
- two records side by side